株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界における体外診断 (IVD) 臨床ラボサービス市場の動向・予測

Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Molecular Diagnostic and Esoteric by Country. 2020 to 2024

発行 Howe Sound Research 商品コード 333656
出版日 ページ情報 英文 307 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.16円で換算しております。
Back to Top
世界における体外診断 (IVD) 臨床ラボサービス市場の動向・予測 Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Molecular Diagnostic and Esoteric by Country. 2020 to 2024
出版日: 2019年11月01日 ページ情報: 英文 307 Pages
概要

当レポートでは、世界の臨床ラボ・分子診断・ゲノム検査サービス市場について取り上げ、主要国および検査領域別の規模・価格・収益データを提供しており、市場における近年の動向、主要企業のプロファイルをまとめ、お届けいたします。

第1章 イントロダクション・市場定義

第2章 動的な市場の概要

  • 市場参入企業
  • 市場区分
  • 臨床試験産業の構造
  • 主要企業のプロファイル
  • 国・地域の多様性

第3章 変化する市場を促進する動向

  • 多くの側面から支えられる成長
  • 市場を収縮させる要因
  • 自動化
  • 環境・発展
  • 診断技術の開発

第4章 ラボ、分子診断およびゲノム検査の近年の動向

第5章 各国の市場規模:北米

  • 米国
    • 臨床化学:規模・価格・収益
    • 微生物学:規模・価格・収益
    • 血液学:規模・価格・収益
    • 解剖病理学:規模・価格・収益
    • 分子診断:規模・価格・収益
    • 全臨床検査:規模・価格・収益
    • エソテリック:規模・価格・収益
  • カナダ

第6章 各国市場:欧州

  • フランス
  • ドイツ
  • 英国
  • スペイン
  • イタリア
  • ロシア
  • その他の欧州

第7章 各国市場:アジア太平洋

  • 中国
  • 日本
  • 韓国
  • インド
  • オーストラリア
  • その他のアジア太平洋

第8章 各国市場:ラテンアメリカ・アフリカ・中東

  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
  • アフリカ・中東

第9章 世界市場のサマリー

  • 世界市場

第10章 臨床ラボの将来

付録

図表

Table of Tables

  • Table 1 Lab Spending 2014 to 2024
  • Table 2 Market Players by Type
  • Table 3 Clinical Laboratory Departments and Segments
  • Table 4 Laboratory Management Focus - Different Approaches
  • Table 5 Key Segmentation Variables Going Forward
  • Table 6 Factors Affecting Local Clinical Testing Demand
  • Table 7 Seven Factors Driving Growth
  • Table 8 Alternative Medicine Creates New Clinical Testing Markets
  • Table 9 Six Factors Limiting Growth
  • Table 10 Key Diagnostic Laboratory Technology Trends
  • Table 11 Next Generation Sequencing Technologies - Speed and Cost
  • Table 12 Key Point of Care Testing Uses
  • Table 13 Clinical Application Areas for Molecular Diagnostics
  • Table 14 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 15 Microbiology - Volume Price and Revenue Forecast
  • Table 16 Hematology - Volume Price and Revenue Forecast
  • Table 17 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 18 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 19 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 20 Esoteric - Volume Price and Revenue Forecast
  • Table 21 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 22 Microbiology - Volume Price and Revenue Forecast
  • Table 23 Hematology - Volume Price and Revenue Forecast
  • Table 24 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 25 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 26 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 27 Esoteric - Volume Price and Revenue Forecast
  • Table 28 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 29 Microbiology - Volume Price and Revenue Forecast
  • Table 30 Hematology - Volume Price and Revenue Forecast
  • Table 31 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 32 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 33 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 34 Esoteric - Volume Price and Revenue Forecast
  • Table 35 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 36 Microbiology - Volume Price and Revenue Forecast
  • Table 37 Hematology - Volume Price and Revenue Forecast
  • Table 38 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 39 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 40 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 41 Esoteric - Volume Price and Revenue Forecast
  • Table 42 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 43 Microbiology - Volume Price and Revenue Forecast
  • Table 44 Hematology - Volume Price and Revenue Forecast
  • Table 45 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 46 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 47 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 48 Esoteric - Volume Price and Revenue Forecast
  • Table 49 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 50 Microbiology - Volume Price and Revenue Forecast
  • Table 51 Hematology - Volume Price and Revenue Forecast
  • Table 52 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 53 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 54 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 55 Esoteric - Volume Price and Revenue Forecast
  • Table 56 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 57 Microbiology - Volume Price and Revenue Forecast
  • Table 58 Hematology - Volume Price and Revenue Forecast
  • Table 59 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 60 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 61 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 62 Esoteric - Volume Price and Revenue Forecast
  • Table 63 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 64 Microbiology - Volume Price and Revenue Forecast
  • Table 65 Hematology - Volume Price and Revenue Forecast
  • Table 66 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 67 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 68 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 69 Esoteric - Volume Price and Revenue Forecast
  • Table 70 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 71 Microbiology - Volume Price and Revenue Forecast
  • Table 72 Hematology - Volume Price and Revenue Forecast
  • Table 73 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 74 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 75 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 76 Esoteric - Volume Price and Revenue Forecast
  • Table 77 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 78 Microbiology - Volume Price and Revenue Forecast
  • Table 79 Hematology - Volume Price and Revenue Forecast
  • Table 80 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 81 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 82 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 83 Esoteric - Volume Price and Revenue Forecast
  • Table 84 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 85 Microbiology - Volume Price and Revenue Forecast
  • Table 86 Hematology - Volume Price and Revenue Forecast
  • Table 87 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 88 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 89 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 90 Esoteric - Volume Price and Revenue Forecast
  • Table 91 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 92 Microbiology - Volume Price and Revenue Forecast
  • Table 93 Hematology - Volume Price and Revenue Forecast
  • Table 94 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 95 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 96 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 97 Esoteric - Volume Price and Revenue Forecast
  • Table 98 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 99 Microbiology - Volume Price and Revenue Forecast
  • Table 100 Hematology - Volume Price and Revenue Forecast
  • Table 101 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 102 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 103 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 104 Esoteric - Volume Price and Revenue Forecast
  • Table 105 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 106 Microbiology - Volume Price and Revenue Forecast
  • Table 107 Hematology - Volume Price and Revenue Forecast
  • Table 108 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 109 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 110 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 111 Esoteric - Volume Price and Revenue Forecast
  • Table 112 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 113 Microbiology - Volume Price and Revenue Forecast
  • Table 114 Hematology - Volume Price and Revenue Forecast
  • Table 115 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 116 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 117 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 118 Esoteric - Volume Price and Revenue Forecast
  • Table 119 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 120 Microbiology - Volume Price and Revenue Forecast
  • Table 121 Hematology - Volume Price and Revenue Forecast
  • Table 122 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 123 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 124 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 125 Esoteric - Volume Price and Revenue Forecast
  • Table 126 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 127 Microbiology - Volume Price and Revenue Forecast
  • Table 128 Hematology - Volume Price and Revenue Forecast
  • Table 129 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 130 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 131 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 132 Esoteric - Volume Price and Revenue Forecast
  • Table 133 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 134 Microbiology - Volume Price and Revenue Forecast
  • Table 135 Hematology - Volume Price and Revenue Forecast
  • Table 136 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 137 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 138 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 139 Esoteric - Volume Price and Revenue Forecast
  • Table 140 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 141 Microbiology - Volume Price and Revenue Forecast
  • Table 142 Hematology - Volume Price and Revenue Forecast
  • Table 143 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 144 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 145 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 146 Esoteric - Volume Price and Revenue Forecast
  • Table 147 Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 148 Microbiology - Volume Price and Revenue Forecast
  • Table 149 Hematology - Volume Price and Revenue Forecast
  • Table 150 Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 151 Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 152 All Clinical Testing - Volume Price and Revenue Forecast
  • Table 153 Esoteric - Volume Price and Revenue Forecast
  • Table 154 2019 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Clinical Lab Spending 2014 to 2024
目次

OVERVIEW:

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations.

Trends like ......

  • the genetic blizzard
  • emerging economies and global prosperity
  • pharmacogenomics
  • healthcare expansion in China
  • climate change
  • globalization
  • automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2018 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

Order an Enterprise Version specifically customized for your organizations needs for distribution throughout your company.

Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. Questions? Email us at service at howesoundresearch.com. We would be glad to let you know if we can be of help.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Clinical Laboratory Services - Strategic Situation Analysis

ii. Guide for Executives, Marketing, Sales and Business Development Staff

iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1 The Growing Demand for Clinical Testing
  • 1.2 Defining the Opportunity
    • 1.2.1 Volumes
    • 1.2.2 Prices
    • 1.2.3 Revenue Market Size
  • 1.3 Methods and Sources
    • 1.3.1 Authors
    • 1.3.2 Sources
  • 1.4 U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Overview of a Dynamic Market

  • 2.1 Market Players - Roles & Impacts
    • 2.1.1 Supplier/pharmaceutical
    • 2.1.2 Independent lab specialized/esoteric
    • 2.1.3 Independent lab national/regional
    • 2.1.4 Independent lab analytical
    • 2.1.5 Public National/regional lab
    • 2.1.6 Hospital lab
    • 2.1.7 Physician lab
    • 2.1.8 Audit body
  • 2.2 Segmentation - Different Approaches
    • 2.2.1 Traditional Market Segmentation
    • 2.2.2 Laboratory Focus and Segmentation
  • 2.3 Structure of Clinical Testing Industry
    • 2.3.1 The Hospital Lab - Share of the Pie
    • 2.3.2 Key Role for Economies of Scale
    • 2.3.3 Physician Office Lab's are Still Here
    • 2.3.4 Physician's and POCT - Reviving Patient Service in China
  • 2.4 Profiles of Key Companies
    • Acibadem Labmed Laboratory
    • ACM Medical Laboratory
    • Adicon Clinical Laboratories
    • American Bio-Clinical Laboratories, Int'l
    • American Pathology Partners
    • ARUP Laboratories
    • Ascend Clinical
    • Aurora Diagnostics
    • Bio-Reference Laboratories
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • BP Healthcare Group
    • Clinical Reference Laboratory
    • Clongen Laboratories
    • CompuNet Clinical Laboratories
    • Diagnósticos da América
    • DIAN Diagnostics Co., Ltd
    • Enzo Life Sciences, Inc.
    • Eurofins Scientific
    • Exagen Diagnostics
    • Genomic Health
    • Genzyme Corporation
    • Gribbles Pathology
    • Guangzhou Kingmed Diagnostics Group Co., Ltd
    • Integrated Regional Laboratories
    • KDL Group
    • Laboratory Corporation of America
    • Lifelabs
    • Mayo Clinic Laboratories
    • Mid America Clinical Laboratories
    • Myriad Genetics/Myriad RBM
    • NeoGenomics
    • Pathology, Inc.
    • Psychemedics Corporation
    • Quest Diagnostics
    • RDL Reference Laboratory
    • Sonic Healthcare
    • Spectra Laboratories
    • Unilabs
  • 2.5 National and Regional Diversity

3. Trends Driving a Changing Market

  • 3.1 Growth Is Pushed from Many Sides
    • 3.1.1 Understanding the Impact of Aging Population.
    • 3.1.2 Economic growth a Key Driver
    • 3.1.3 Point of Care Testing can increase demand
    • 3.1.4 Alternative Medicine Creates Testing Opportunity
    • 3.1.5 Esoteric Testing Moving Mainstream
    • 3.1.6 Genetic Based Testing Creates New Department and New Discipline
  • 3.2 Factors at Work To Shrink The Market
    • 3.2.1 Lower costs trend to continue
    • 3.2.2 Economic or population contraction.
    • 3.2.3 Testing usage analysis curtailing growth.
    • 3.2.4 Wellness has a downside
    • 3.2.5 Test Displacement Impacts Important
    • 3.2.6 Point of Care Testing
  • 3.3 Automation
    • 3.3.1 Stranded LIMS Investment
    • 3.3.2 Software as a Service
    • 3.3.3 Physician Office and Access Systems
  • 3.4 Environment and Evolution
  • 3.5 Diagnostic Technology Development
    • 3.5.1 Next Generation Sequencing Fuels a Revolution.
    • 3.5.2 Impact of NGS on pricing
    • 3.5.3 POCT/Self Testing Disruptive Force
    • 3.5.4 Pharmacogenomics Blurs Diagnosis and Treatment
    • 3.5.5 CGES Testing, A Brave New World
    • 3.5.6 Molecular Diagnostics Technologies at The Forefront of Growth
    • 3.5.7 Biochips/Giant magneto resistance based assay

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

  • 4.1 Recent Developments - Importance and How to Use This Section
    • 4.1.1 Importance of These Developments
    • 4.1.2 How to Use This Section
      • CLA Urges FDA to Halt Crackdown on PGx Testing
      • Quest Diagnostics Subsidiary Buys True Health Dx Assets
      • BioReference Laboratories selected by IPA Association
      • Predictive Laboratories Announces Research Collaboration
      • NEOMED-LABS / Pacific Biomarkers Acquires PAIRimmune Français
      • LabCorp and Envigo Complete Transactions
      • PathGroup Acquires Pathologists Bio-Medical Laboratories
      • Predictive Technology Acquires Taueret Laboratories
      • Quest Diagnostics Acquires Laboratory Services Business of Boyce & Bynum Pathology
      • Laboratories
      • Gestalt Diagnostics Expands Market Reach with Peak Medical Acquisition
      • Amazon exploring consumer health diagnostics
      • Quest Diagnostics Acquires Laboratory Services Operation in Central Michigan
      • NeoGenomics to acquire Genoptix, Inc
      • Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
      • Charles River Labs to acquire contract research firm for $800M
      • GROUPE BIO7 to be Sold to CERBA HEALTHCARE
      • GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
      • Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies
      • PSP to acquire European medical lab services company
      • Mars, Incorporated to Acquire VCA Inc.
      • Grifols acquires Hologic's blood screening unit for $1.85bn
      • LabCorp to acquire clinical laboratories from Mount Sinai
      • PerkinElmer to buy Germany's Euroimmun for about $1.3 billion
      • LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash
      • Precipio Diagnostics and Transgenomic Complete Merger
      • $550 Dock Turns a Smartphone into a Medical Lab
      • LabCorp & Interpace Extend Deal, Boost Cancer Portfolio
      • Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care
      • Quest Diagnostics to Acquire MedXM
      • Overview of Clinical Diagnostic Acquisition Activity
      • New Sysmex Device Provides Blood Test Results at Point of Care in Minutes
      • FDA, Congress Return Attention to Direct-to-Consumer Genetic Testing
      • QIAGEN Enters into Agreement to Acquire STAT-Dx

5. Country Market Sizes - North America 2016 to 2024

  • 5.1 United States of America 2016 to 2024
    • 5.1.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 5.1.2 Microbiology - Volumes, Prices, Revenues
    • 5.1.3 Hematology - Volumes, Prices, Revenues
    • 5.1.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 5.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 5.1.6 All Clinical Testing - Volumes, Prices, Revenues
    • 5.1.7 Esoteric - Volumes, Prices, Revenues
  • 5.2 Canada 2016 to 2024
    • 5.2.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 5.2.2 Microbiology - Volumes, Prices, Revenues
    • 5.2.3 Hematology - Volumes, Prices, Revenues
    • 5.2.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 5.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 5.2.6 All Clinical Testing - Volumes, Prices, Revenues
    • 5.2.7 Esoteric - Volumes, Prices, Revenues

6. Country Markets - Europe 2016 to 2024

  • 6.1 France 2016 to 2024
    • 6.1.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 6.1.2 Microbiology - Volumes, Prices, Revenues
    • 6.1.3 Hematology - Volumes, Prices, Revenues
    • 6.1.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 6.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.1.6 All Clinical Testing - Volumes, Prices, Revenues
    • 6.1.7 Esoteric - Volumes, Prices, Revenues
  • 6.2 Germany 2016 to 2024
    • 6.2.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 6.2.2 Microbiology - Volumes, Prices, Revenues
    • 6.2.3 Hematology - Volumes, Prices, Revenues
    • 6.2.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 6.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.2.6 All Clinical Testing - Volumes, Prices, Revenues
    • 6.2.7 Esoteric - Volumes, Prices, Revenues
  • 6.3 United Kingdom 2016 to 2024
    • 6.3.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 6.3.2 Microbiology - Volumes, Prices, Revenues
    • 6.3.3 Hematology - Volumes, Prices, Revenues
    • 6.3.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 6.3.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.3.6 All Clinical Testing - Volumes, Prices, Revenues
    • 6.3.7 Esoteric - Volumes, Prices, Revenues
  • 6.4 Spain 2016 to 2024
    • 6.4.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 6.4.2 Microbiology - Volumes, Prices, Revenues
    • 6.4.3 Hematology - Volumes, Prices, Revenues
    • 6.4.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 6.4.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.4.6 All Clinical Testing - Volumes, Prices, Revenues
    • 6.4.7 Esoteric - Volumes, Prices, Revenues
  • 6.5 Italy 2016 to 2024
    • 6.5.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 6.5.2 Microbiology - Volumes, Prices, Revenues
    • 6.5.3 Hematology - Volumes, Prices, Revenues
    • 6.5.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 6.5.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.5.6 All Clinical Testing - Volumes, Prices, Revenues
    • 6.5.7 Esoteric - Volumes, Prices, Revenues
  • 6.6 Russia 2016 to 2024
    • 6.6.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 6.6.2 Microbiology - Volumes, Prices, Revenues
    • 6.6.3 Hematology - Volumes, Prices, Revenues
    • 6.6.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 6.6.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.6.6 All Clinical Testing - Volumes, Prices, Revenues
    • 6.6.7 Esoteric - Volumes, Prices, Revenues
  • 6.7 Remainder of Europe and Former Soviet Union 2016 to 2024
    • 6.7.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 6.7.2 Microbiology - Volumes, Prices, Revenues
    • 6.7.3 Hematology - Volumes, Prices, Revenues
    • 6.7.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 6.7.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.7.6 All Clinical Testing - Volumes, Prices, Revenues
    • 6.7.7 Esoteric - Volumes, Prices, Revenues

7. Country Markets - Asia Pacific 2016 to 2024

  • 7.1 China 2016 to 2024
    • 7.1.2 Microbiology - Volumes, Prices, Revenues
    • 7.1.3 Hematology - Volumes, Prices, Revenues
    • 7.1.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 7.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.1.6 All Clinical Testing - Volumes, Prices, Revenues
    • 7.1.7 Esoteric - Volumes, Prices, Revenues
  • 7.2 Japan 2016 to 2024
    • 7.2.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 7.2.2 Microbiology - Volumes, Prices, Revenues
    • 7.2.3 Hematology - Volumes, Prices, Revenues
    • 7.2.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 7.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.2.6 All Clinical Testing - Volumes, Prices, Revenues
    • 7.2.7 Esoteric - Volumes, Prices, Revenues
  • 7.3 South Korea 2016 to 2024
    • 7.3.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 7.3.2 Microbiology - Volumes, Prices, Revenues
    • 7.3.3 Hematology - Volumes, Prices, Revenues
    • 7.3.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 7.3.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.3.6 All Clinical Testing - Volumes, Prices, Revenues
    • 7.3.7 Esoteric - Volumes, Prices, Revenues
  • 7.4 India 2016 to 2024
    • 7.4.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 7.4.2 Microbiology - Volumes, Prices, Revenues
    • 7.4.3 Hematology - Volumes, Prices, Revenues
    • 7.4.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 7.4.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.4.6 All Clinical Testing - Volumes, Prices, Revenues
    • 7.4.7 Esoteric - Volumes, Prices, Revenues
  • 7.5 Australia 2016 to 2024
    • 7.5.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 7.5.2 Microbiology - Volumes, Prices, Revenues
    • 7.5.3 Hematology - Volumes, Prices, Revenues
    • 7.5.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 7.5.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.5.6 All Clinical Testing - Volumes, Prices, Revenues
    • 7.5.7 Esoteric - Volumes, Prices, Revenues
  • 7.6 Rest of Asia Pacific 2016 to 2024
    • 7.6.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 7.6.2 Microbiology - Volumes, Prices, Revenues
    • 7.6.3 Hematology - Volumes, Prices, Revenues
    • 7.6.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 7.6.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.6.6 All Clinical Testing - Volumes, Prices, Revenues
    • 7.6.7 Esoteric - Volumes, Prices, Revenues

8. Country Markets - Latin America, Africa & The Middle East 2016 to 2024

  • 8.1 Brazil 2016 to 2024
    • 8.1.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 8.1.2 Microbiology - Volumes, Prices, Revenues
    • 8.1.3 Hematology - Volumes, Prices, Revenues
    • 8.1.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 8.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.1.6 All Clinical Testing - Volumes, Prices, Revenues
    • 8.1.7 Esoteric - Volumes, Prices, Revenues
  • 8.2 Mexico 2016 to 2024
    • 8.2.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 8.2.2 Microbiology - Volumes, Prices, Revenues
    • 8.2.3 Hematology - Volumes, Prices, Revenues
    • 8.2.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 8.2.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.2.6 All Clinical Testing - Volumes, Prices, Revenues
    • 8.2.7 Esoteric - Volumes, Prices, Revenues
  • 8.3 Remainder of Latin America 2016 to 2024
    • 8.3.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 8.3.2 Microbiology - Volumes, Prices, Revenues
    • 8.3.3 Hematology - Volumes, Prices, Revenues
    • 8.3.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 8.3.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.3.6 All Clinical Testing - Volumes, Prices, Revenues
    • 8.3.7 Esoteric - Volumes, Prices, Revenues
  • 8.4 Africa & The Middle East 2016 to 2024
    • 8.4.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 8.4.2 Microbiology - Volumes, Prices, Revenues
    • 8.4.3 Hematology - Volumes, Prices, Revenues
    • 8.4.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 8.4.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.4.6 All Clinical Testing - Volumes, Prices, Revenues
    • 8.4.7 Esoteric - Volumes, Prices, Revenues

9. Global Market Summary 2016 to 2024

  • 9.1 Global Market 2016 to 2024
    • 9.1.1 Clinical Chemistry - Volumes, Prices, Revenues
    • 9.1.2 Microbiology - Volumes, Prices, Revenues
    • 9.1.3 Hematology - Volumes, Prices, Revenues
    • 9.1.4 Anatomic Pathology - Volumes, Prices, Revenues
    • 9.1.5 Molecular Diagnostics - Volumes, Prices, Revenues
    • 9.1.6 All Clinical Testing - Volumes, Prices, Revenues
    • 9.1.7 Esoteric - Volumes, Prices, Revenues

10. The Future of the Clinical Laboratory

Appendices

  • I. United States Medicare System: January 2019 Clinical Laboratory Fees Schedule
Back to Top